News

GSK invests $95 million in effort to demystify cell 'operating system'


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

GSK invests $95 million in effort to demystify cell 'operating system'


Date: 17/06/2015

British drugmaker GlaxoSmithKline is investing $95 million to create a new U.S. research institute led by a top genomics professor to investigate how a cell's operating system works.

The move reflects a commitment to fundamental research by the British company, even as its shifts emphasis to greater reliance on non-pharmaceutical businesses such as consumer healthcare and vaccines.

Cells are often referred to as the building blocks of life, but they can be thought of in computer terms, with their own internal operating systems. Scientists have only limited understanding of this area, but by unpicking the puzzle they could gain invaluable help in determining where to start when developing drugs.

For more click here

Source: Reuters

© Catalyst Innovation Portal 2019